Do analysts prefer PRG or IBEX?

PROG currently has a consensus price target of $43.70, suggesting a potential downside of 6.47%. IBEX has a consensus price target of $40.00, suggesting a potential upside of 31.71%. Given IBEX's higher probable upside, analysts clearly believe IBEX is more favorable than PROG. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROG 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86 IBEX 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, PRG or IBEX?

PROG has higher revenue and earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than PROG, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PROG $2.41B 0.78 $146.79M $3.66 12.77 IBEX $558.27M 0.73 $36.86M $3.20 9.49

Is PRG or IBEX more profitable?

IBEX has a net margin of 7.53% compared to PROG's net margin of 5.88%. IBEX's return on equity of 31.50% beat PROG's return on equity. Company Net Margins Return on Equity Return on Assets PROG 5.88% 21.94% 9.54% IBEX 7.53% 31.50% 16.25%

Does the media favor PRG or IBEX?

In the previous week, IBEX had 3 more articles in the media than PROG. MarketBeat recorded 5 mentions for IBEX and 2 mentions for PROG. PROG's average media sentiment score of 0.50 beat IBEX's score of 0.27 indicating that PROG is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROG 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IBEX 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, IBEX or EVTC?

Evertec has higher revenue and earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IBEX $558.27M 0.73 $36.86M $3.20 9.49 Evertec $931.82M 1.84 $141.59M $2.07 13.43

Is IBEX or EVTC more profitable?

Evertec has a net margin of 13.95% compared to IBEX's net margin of 7.53%. IBEX's return on equity of 31.50% beat Evertec's return on equity. Company Net Margins Return on Equity Return on Assets IBEX 7.53% 31.50% 16.25% Evertec 13.95% 31.40% 9.36%

Does the media prefer IBEX or EVTC?

In the previous week, IBEX had 4 more articles in the media than Evertec. MarketBeat recorded 5 mentions for IBEX and 1 mentions for Evertec. IBEX's average media sentiment score of 0.27 beat Evertec's score of 0.00 indicating that IBEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IBEX 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evertec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CNXC or IBEX more profitable?

IBEX has a net margin of 7.53% compared to Concentrix's net margin of -13.16%. IBEX's return on equity of 31.50% beat Concentrix's return on equity. Company Net Margins Return on Equity Return on Assets Concentrix -13.16% 18.93% 5.52% IBEX 7.53% 31.50% 16.25%

Does the media favor CNXC or IBEX?

In the previous week, Concentrix had 28 more articles in the media than IBEX. MarketBeat recorded 33 mentions for Concentrix and 5 mentions for IBEX. IBEX's average media sentiment score of 0.27 beat Concentrix's score of 0.21 indicating that IBEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Concentrix 5 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral IBEX 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, NEO or IBEX?

IBEX has lower revenue, but higher earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than IBEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeoGenomics $727.33M 2.61 -$108.03M -$0.77 N/A IBEX $558.27M 0.73 $36.86M $3.20 9.49

Is NEO or IBEX more profitable?

IBEX has a net margin of 7.53% compared to NeoGenomics' net margin of -13.30%. IBEX's return on equity of 31.50% beat NeoGenomics' return on equity. Company Net Margins Return on Equity Return on Assets NeoGenomics -13.30% -2.80% -1.72% IBEX 7.53% 31.50% 16.25%

Does the media favor NEO or IBEX?

In the previous week, NeoGenomics had 1 more articles in the media than IBEX. MarketBeat recorded 6 mentions for NeoGenomics and 5 mentions for IBEX. NeoGenomics' average media sentiment score of 0.31 beat IBEX's score of 0.27 indicating that NeoGenomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IBEX 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, IBEX or BRAI?

IBEX has higher revenue and earnings than Braiin. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IBEX $558.27M 0.73 $36.86M $3.20 9.49 Braiin $73.41M 17.18 N/A N/A N/A

Is IBEX or BRAI more profitable?

IBEX has a net margin of 7.53% compared to Braiin's net margin of 0.00%. IBEX's return on equity of 31.50% beat Braiin's return on equity. Company Net Margins Return on Equity Return on Assets IBEX 7.53% 31.50% 16.25% Braiin N/A N/A N/A

Does the media refer more to IBEX or BRAI?

In the previous week, Braiin had 10 more articles in the media than IBEX. MarketBeat recorded 15 mentions for Braiin and 5 mentions for IBEX. IBEX's average media sentiment score of 0.27 beat Braiin's score of 0.23 indicating that IBEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IBEX 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Braiin 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral

IBEX (IBEX) Competitors

$30.37 +0.24 (+0.80%)

Closing price 04:00 PM Eastern

Extended Trading

$30.36 -0.01 (-0.03%)

As of 04:14 PM Eastern

Compare

IBEX vs. PRG, EVTC, CNXC, NEO, and BRAI

Should you buy IBEX stock or one of its competitors? MarketBeat compares IBEX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IBEX include PROG (PRG), Evertec (EVTC), Concentrix (CNXC), NeoGenomics (NEO), and Braiin (BRAI). These companies are all part of the "business services" industry.

How does IBEX compare to PROG?

PROG (NYSE:PRG) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

PROG has higher revenue and earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than PROG, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROG	$2.41B	0.78	$146.79M	$3.66	12.77
IBEX	$558.27M	0.73	$36.86M	$3.20	9.49

97.9% of PROG shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 3.7% of PROG shares are owned by company insiders. Comparatively, 3.4% of IBEX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

PROG has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market. Comparatively, IBEX has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

PROG currently has a consensus price target of $43.70, suggesting a potential downside of 6.47%. IBEX has a consensus price target of $40.00, suggesting a potential upside of 31.71%. Given IBEX's higher probable upside, analysts clearly believe IBEX is more favorable than PROG.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROG	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

IBEX has a net margin of 7.53% compared to PROG's net margin of 5.88%. IBEX's return on equity of 31.50% beat PROG's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROG	5.88%	21.94%	9.54%
IBEX	7.53%	31.50%	16.25%

In the previous week, IBEX had 3 more articles in the media than PROG. MarketBeat recorded 5 mentions for IBEX and 2 mentions for PROG. PROG's average media sentiment score of 0.50 beat IBEX's score of 0.27 indicating that PROG is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROG	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PROG beats IBEX on 12 of the 17 factors compared between the two stocks.

How does IBEX compare to Evertec?

IBEX (NASDAQ:IBEX) and Evertec (NYSE:EVTC) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

IBEX presently has a consensus price target of $40.00, indicating a potential upside of 31.71%. Evertec has a consensus price target of $33.20, indicating a potential upside of 19.46%. Given IBEX's higher probable upside, research analysts clearly believe IBEX is more favorable than Evertec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Evertec	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

81.2% of IBEX shares are held by institutional investors. Comparatively, 96.8% of Evertec shares are held by institutional investors. 3.4% of IBEX shares are held by insiders. Comparatively, 1.1% of Evertec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IBEX has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Evertec has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

Evertec has higher revenue and earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IBEX	$558.27M	0.73	$36.86M	$3.20	9.49
Evertec	$931.82M	1.84	$141.59M	$2.07	13.43

Evertec has a net margin of 13.95% compared to IBEX's net margin of 7.53%. IBEX's return on equity of 31.50% beat Evertec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IBEX	7.53%	31.50%	16.25%
Evertec	13.95%	31.40%	9.36%

In the previous week, IBEX had 4 more articles in the media than Evertec. MarketBeat recorded 5 mentions for IBEX and 1 mentions for Evertec. IBEX's average media sentiment score of 0.27 beat Evertec's score of 0.00 indicating that IBEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evertec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Evertec beats IBEX on 9 of the 16 factors compared between the two stocks.

How does IBEX compare to Concentrix?

Concentrix (NASDAQ:CNXC) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

90.3% of Concentrix shares are held by institutional investors. Comparatively, 81.2% of IBEX shares are held by institutional investors. 0.9% of Concentrix shares are held by insiders. Comparatively, 3.4% of IBEX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

IBEX has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than IBEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentrix	$9.83B	0.14	-$1.28B	-$21.55	N/A
IBEX	$558.27M	0.73	$36.86M	$3.20	9.49

Concentrix currently has a consensus price target of $32.75, suggesting a potential upside of 46.14%. IBEX has a consensus price target of $40.00, suggesting a potential upside of 31.71%. Given Concentrix's stronger consensus rating and higher probable upside, equities analysts plainly believe Concentrix is more favorable than IBEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentrix	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

IBEX has a net margin of 7.53% compared to Concentrix's net margin of -13.16%. IBEX's return on equity of 31.50% beat Concentrix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concentrix	-13.16%	18.93%	5.52%
IBEX	7.53%	31.50%	16.25%

In the previous week, Concentrix had 28 more articles in the media than IBEX. MarketBeat recorded 33 mentions for Concentrix and 5 mentions for IBEX. IBEX's average media sentiment score of 0.27 beat Concentrix's score of 0.21 indicating that IBEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concentrix	5 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concentrix has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market. Comparatively, IBEX has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market.

Summary

IBEX beats Concentrix on 10 of the 16 factors compared between the two stocks.

How does IBEX compare to NeoGenomics?

NeoGenomics (NASDAQ:NEO) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

In the previous week, NeoGenomics had 1 more articles in the media than IBEX. MarketBeat recorded 6 mentions for NeoGenomics and 5 mentions for IBEX. NeoGenomics' average media sentiment score of 0.31 beat IBEX's score of 0.27 indicating that NeoGenomics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NeoGenomics has a beta of 1.82, suggesting that its share price is 82% more volatile than the broader market. Comparatively, IBEX has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market.

NeoGenomics currently has a consensus price target of $13.86, suggesting a potential downside of 5.02%. IBEX has a consensus price target of $40.00, suggesting a potential upside of 31.71%. Given IBEX's higher probable upside, analysts plainly believe IBEX is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

IBEX has lower revenue, but higher earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than IBEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	2.61	-$108.03M	-$0.77	N/A
IBEX	$558.27M	0.73	$36.86M	$3.20	9.49

98.5% of NeoGenomics shares are held by institutional investors. Comparatively, 81.2% of IBEX shares are held by institutional investors. 1.1% of NeoGenomics shares are held by insiders. Comparatively, 3.4% of IBEX shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

IBEX has a net margin of 7.53% compared to NeoGenomics' net margin of -13.30%. IBEX's return on equity of 31.50% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
IBEX	7.53%	31.50%	16.25%

Summary

NeoGenomics and IBEX tied by winning 8 of the 16 factors compared between the two stocks.

How does IBEX compare to Braiin?

IBEX (NASDAQ:IBEX) and Braiin (NASDAQ:BRAI) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

IBEX has a net margin of 7.53% compared to Braiin's net margin of 0.00%. IBEX's return on equity of 31.50% beat Braiin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IBEX	7.53%	31.50%	16.25%
Braiin	N/A	N/A	N/A

In the previous week, Braiin had 10 more articles in the media than IBEX. MarketBeat recorded 15 mentions for Braiin and 5 mentions for IBEX. IBEX's average media sentiment score of 0.27 beat Braiin's score of 0.23 indicating that IBEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IBEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Braiin	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

81.2% of IBEX shares are owned by institutional investors. 3.4% of IBEX shares are owned by insiders. Comparatively, 47.9% of Braiin shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

IBEX has higher revenue and earnings than Braiin.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IBEX	$558.27M	0.73	$36.86M	$3.20	9.49
Braiin	$73.41M	17.18	N/A	N/A	N/A

IBEX presently has a consensus price target of $40.00, indicating a potential upside of 31.71%. Braiin has a consensus price target of $10.00, indicating a potential upside of 63.40%. Given Braiin's higher possible upside, analysts plainly believe Braiin is more favorable than IBEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IBEX	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Braiin	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

IBEX beats Braiin on 6 of the 11 factors compared between the two stocks.

Get IBEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IBEX vs. The Competition

Export

Metric	IBEX	BUSINESS SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$403.41M	$5.43B	$6.83B	$12.45B
Dividend Yield	N/A	2.95%	3.16%	6.16%
P/E Ratio	9.49	12.36	30.26	24.87
Price / Sales	0.73	1.44	364.40	102.84
Price / Cash	7.18	11.54	23.56	58.59
Price / Book	3.02	4.95	5.89	6.54
Net Income	$36.86M	$154.43M	$203.69M	$336.70M
7 Day Performance	2.57%	-1.86%	0.53%	3.31%
1 Month Performance	-4.01%	-4.37%	-3.12%	1.68%
1 Year Performance	4.36%	-3.27%	27.03%	31.96%

IBEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IBEX IBEX	2.9262 of 5 stars	$30.37 +0.8%	$40.00 +31.7%	+5.7%	$403.41M	$558.27M	9.49	33,000
PRG PROG	3.3899 of 5 stars	$39.19 +0.5%	$43.70 +11.5%	+56.2%	$1.55B	$2.41B	10.60	1,151
EVTC Evertec	4.8053 of 5 stars	$25.06 -0.6%	$33.20 +32.5%	-23.3%	$1.55B	$950.95M	12.13	5,327	Positive News
CNXC Concentrix	4.8568 of 5 stars	$24.22 +1.2%	$48.50 +100.2%	-51.2%	$1.49B	$9.83B	N/A	455,000	Trending News Earnings Report Dividend Announcement Analyst Forecast Gap Down
NEO NeoGenomics	1.3716 of 5 stars	$11.39 +1.7%	$13.86 +21.7%	+98.5%	$1.49B	$727.33M	N/A	2,500	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IBEX) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IBEX (IBEX) Competitors